The National Marrow Donation Program (NMDP), which maintains the “Be The Match” registry to help provide individuals who would benefit from bone marrow donation with potential donors, is currently at odds with a ruling made by the Ninth Circuit Court in California. The court ruled that, while it’s not legal to compensate organ donors in the United States for their donation, one of the bone marrow-donating procedures isn’t “technically” organ donation — it’s blood donation — and donors can therefore be compensated.
In a continuing effort to educate the public on the dangers of cigarette smoking, the FDA intended to require cigarette manufacturers to post large, graphic images on packages of cigarettes. This effort has been temporarily halted by an injunction passed down from U.S. District Court Judge Richard Leon last month. The FDA’s law blog explains that Judge Leon felt the warnings were not “purely factual and noncontroversial disclosures” and that “the Government’s actual purpose is not to inform, but rather to advocate a change in consumer behavior.”
In September, GE and leading healthcare and financial partners launched a new healthymagination initiative focused on accelerating cancer innovation and improving care for 10 million cancer patients around the world by 2020 . The plan was announced in New York by GE’s CEO and Chairman Jeff Immelt to an audience of prominent cancer scientists and researchers, doctors, financial partners and employees of GE Healthcare. The company’s comprehensive initiative combines the strength of GE’s portfolio of integrated cancer technologies with collaboration between GE and new partners and data sources to help clinicians provide better, more personalized care.
Last Thursday, the Centers for Medicare & Medicaid Services (CMS) released the highly anticipated final regulations for accountable care organizations (ACOs) under Section 3022 of the Patient Protection and Affordable Care Act (PPACA) . The PPACA requires accountable-care agreements to be offered under Medicare, starting in 2012.
So-called “Frankenfood” — genetically-modified organisms meant for human consumption or use as animal feed — has been making headlines again. This time, the buzz is over the FDA’s recent completion of their evaluation of the first genetically-engineered (GE) salmon meant for human consumption, the AquAdvantage salmon. The White House’s Office of Management and Budget is now reviewing the evaluation, which puts the AquAdvantage salmon one critical step closer to finding its way into farms and onto plates. While the GE salmon would be the first genetically-modified animal approved for human consumption, it’s not the first genetically-modified organism (GMO) used for food; data from 2009 indicate that 93% of soy and cotton, and 86% of corn grown in the U.S. are GMO . There are a number of other common GMO crops, and GMO rice will likely become available soon.